XML 54 R40.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 1 - Description of Business and Significant Accounting Policies (Details Textual)
$ in Thousands
12 Months Ended
Oct. 12, 2016
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Number of Operating Segments   1  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00%  
Payments of Dividends   $ 0  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense   0 $ 0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued   $ 0 $ 0
Minimum [Member]      
Finite-Lived Intangible Asset, Useful Life   5 years  
Maximum [Member]      
Finite-Lived Intangible Asset, Useful Life   20 years  
Laboratory Equipment, Office Equipment and Furniture And Fixtures [Member] | Minimum [Member]      
Property, Plant and Equipment, Useful Life   3 years  
Laboratory Equipment, Office Equipment and Furniture And Fixtures [Member] | Maximum [Member]      
Property, Plant and Equipment, Useful Life   10 years  
Software Development [Member]      
Property, Plant and Equipment, Useful Life   3 years  
Specialized Shipping Containers [Member]      
Property, Plant and Equipment, Useful Life   3 years  
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]      
Number of Major Customers   2  
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Shanghai Fosun Long March Medical Science Co. Ltd. [Member]      
Concentration Risk, Percentage   15.00%  
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Riken Genesis Co., Ltd. [Member]      
Concentration Risk, Percentage   14.00%  
Immunetics [Member]      
Payments to Acquire Businesses, Gross $ 6,000    
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 6,000    
Business Combination, Contingent Consideration Arrangement, Term of Milestone Achievement 3 years